PA8661101A1 - Compuestos antihelminticos - Google Patents

Compuestos antihelminticos

Info

Publication number
PA8661101A1
PA8661101A1 PA20068661101A PA8661101A PA8661101A1 PA 8661101 A1 PA8661101 A1 PA 8661101A1 PA 20068661101 A PA20068661101 A PA 20068661101A PA 8661101 A PA8661101 A PA 8661101A PA 8661101 A1 PA8661101 A1 PA 8661101A1
Authority
PA
Panama
Prior art keywords
compositions
antihelmintic
tetrahidro
preparations
new
Prior art date
Application number
PA20068661101A
Other languages
English (en)
Inventor
Jan Heeres
Paul Adriaan Jan Janssen
Paulus Joannes Lewi
Frank Xavier Josef Herwig Arts
Kathleen Marie Jeanne Alice Vlaminck
Pierre Jozef Hektor Valere Ottevaere
Oscar Franz Joseph Vanparijs
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PA8661101A1 publication Critical patent/PA8661101A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL NUEVO COMPUESTO ANTIHELMINTICO [3-(2,3,5,6-TETRAHIDRO-IMIDAZOL[2,1-B]TIAZOL-6-IL]-FENIL]-AMIDA DE ACIDO TETRAHIDRO-FURAN-2-CARBOXILICO Y A SUS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES Y A LAS FORMAS ESTEREOQUIMICAMENTE ISOMERICAS DE ESTOS, ASI COMO TAMBIEN A LAS COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN DICHO NUEVO COMPUESTO, A LOS PROCEDIMIENTOS PARA PREPARAR DICHOS COMPUESTOS Y COMPOSICIONES, Y AL USO DE ESTOS COMO MEDICAMENTO, EN PARTICULAR EN EL TRATAMIENTO, CONTROL Y PREVENCION DE INFECCIONES ENDO- Y ECTOPARASITICAS EN ANIMALES DE SANGRE CALIENTE.
PA20068661101A 2005-01-28 2006-01-26 Compuestos antihelminticos PA8661101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05100580 2005-01-28

Publications (1)

Publication Number Publication Date
PA8661101A1 true PA8661101A1 (es) 2006-09-22

Family

ID=34938598

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20068661101A PA8661101A1 (es) 2005-01-28 2006-01-26 Compuestos antihelminticos

Country Status (17)

Country Link
US (1) US20080287511A1 (es)
EP (1) EP1844055A1 (es)
JP (1) JP2008528550A (es)
KR (1) KR20070106990A (es)
CN (1) CN101107255A (es)
AR (1) AR052365A1 (es)
AU (1) AU2006208712A1 (es)
BR (1) BRPI0606869A2 (es)
CA (1) CA2589221A1 (es)
EA (1) EA011024B1 (es)
IL (1) IL184862A0 (es)
MX (1) MX2007009168A (es)
NO (1) NO20074371L (es)
NZ (1) NZ555541A (es)
PA (1) PA8661101A1 (es)
TW (1) TW200640933A (es)
WO (1) WO2006079642A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013024898A1 (ja) 2011-08-18 2013-02-21 日本新薬株式会社 ヘテロ環誘導体及び医薬
CN102675346A (zh) * 2012-05-28 2012-09-19 重庆大学 一种左旋咪唑有机酸盐，其合成方法和它的药物组合物
KR20200020911A (ko) * 2017-06-30 2020-02-26 바이엘 애니멀 헬스 게엠베하 새로운 아자퀴놀린 유도체
EP3634959A1 (en) * 2017-08-04 2020-04-15 Bayer Animal Health GmbH Quinoline derivatives for treating infections with helminths
CN111138457A (zh) * 2019-12-19 2020-05-12 山东国邦药业有限公司 一种盐酸四咪唑的合成方法
CN112358490B (zh) * 2020-12-10 2021-11-09 山东国邦药业有限公司 一种盐酸四咪唑的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365515A (en) * 1971-09-03 1974-09-04 American Cyanamid Co 6-tetrahydro imidazol/2 1-b/thiazoles
ZA735753B (en) * 1972-09-14 1974-07-31 American Cyanamid Co Resolution of 6-substituted amino phenyl-2,3,5,6-tetrahydro(2,1-b)thiadiazoles
US4014892A (en) * 1972-09-14 1977-03-29 American Cyanamid Company 6-Substituted amino phenyl-2,3,5,6-tetrahydro[2,1-b]thiazoles

Also Published As

Publication number Publication date
EP1844055A1 (en) 2007-10-17
JP2008528550A (ja) 2008-07-31
CA2589221A1 (en) 2006-08-03
WO2006079642A1 (en) 2006-08-03
BRPI0606869A2 (pt) 2009-07-21
KR20070106990A (ko) 2007-11-06
AR052365A1 (es) 2007-03-14
AU2006208712A1 (en) 2006-08-03
MX2007009168A (es) 2007-08-14
NZ555541A (en) 2009-08-28
US20080287511A1 (en) 2008-11-20
NO20074371L (no) 2007-08-28
EA011024B1 (ru) 2008-12-30
IL184862A0 (en) 2007-12-03
TW200640933A (en) 2006-12-01
EA200701601A1 (ru) 2007-12-28
CN101107255A (zh) 2008-01-16

Similar Documents

Publication Publication Date Title
HN2005000795A (es) Pirimidinas como antagonistas del receptor de prostaglandina d2
CL2012000033A1 (es) Compuestos n-(3-(4as,7as)-2-amino-4a,5,7,7a-tetrahidro-4h-furo[3,4-d][1,3] tiazin-7a-il)-4- fluorofenilo) -5-fluoropiconilamida, inhibidor de bace; composicion farmaceutica que los comprende, uso del compuesto para el tratamiento de la enfermedad de alzheimer.
HN2011001593A (es) Piridiloxi-indoles del vegf-r2 y uso de los mismos para el tratmiento de enfermedades
UY37831A (es) Nuevos derivados de quinolina
PA8780201A1 (es) Derivados de pirasol sustituidos con heteroaril utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
CO6280440A2 (es) Derivados de aminobenzamida como agentes utiles para el control de parasito de animales
CR10304A (es) Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos
ECSP077324A (es) Amidas bicíclicas como inhibidores de cinasa
GT200600316A (es) Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
GT200500307A (es) Compuestos quimicos
SV2009003299A (es) Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa
CR9034A (es) Preparacion y uso de derivados de acido bifenil-4-il-carbonilamino para el tratamiento de la obesidad
HN2003000417A (es) Intermedio de formulacion aceptablemente no higroscopico que comprende un farmaco higroscopico
DOP2006000235A (es) Derivados de acidos dicarboxilicos y su uso
CR10489A (es) Derivados fenil-pirazol como ligandos de receptores glucocorticoides no esteroides
DOP2002000422A (es) Agentes antibacterianos.
ME01456B (me) Fumaratna so (alfa s, beta r)-6-bromo-alfa-[2-(dimetilamino)etil]-2-metoksi-alfa-1-naftalenil-beta-fenil-3-kinolinetanola
UY29648A1 (es) Derivados de piridopirimidina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
DOP2019000275A (es) Nuevos derivados de pirazol bicíclicos
CL2020002891A1 (es) Nuevos derivados de quinolina
PA8661101A1 (es) Compuestos antihelminticos
SV2006002290A (es) Nonadepsipeptidos acilados ii ref. bhc041327-sv
CR10255A (es) "nuevas composiciones terapéuticas para el tratamiento o la prevención de trastornos psicóticos"
HN2011000404A (es) Derivados de enfumafungina y composicion comprendiendo los mismos